Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Pharmaceutical Design|May 16, 2009
Kv7 channels as targets for the treatment of painA D Wickenden, G McNaughton-SmithAmerican Journal of Physiology. Cell Physiology|May 12, 2010
Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilationT G Banke, S R Chaplan, A D WickendenCurrent Pharmaceutical Design|June 13, 2009
HCN pacemaker channels and pain: a drug discovery perspectiveA D Wickenden, M P Maher, S R ChaplanBritish Journal of Pharmacology|June 1, 1988
The physiological relevance of low agonist affinity binding at opioid mu-receptorsJ A Carroll, J S Shaw, A D WickendenBritish Journal of Pharmacology|February 13, 2001
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cellsA D Wickenden, A Zou, P K Wagoner, et al.American Journal of Physiology. Heart and Circulatory Physiology|April 6, 2000
The thyroid hormone analog DITPA restores I(to) in rats after myocardial infarctionA D Wickenden, R Kaprielian, X M You, et al.The American Journal of Physiology|May 18, 1999
Regional contributions of Kv1.4, Kv4.2, and Kv4.3 to transient outward K+ current in rat ventricleA D Wickenden, T J Jegla, R Kaprielian, et al.British Journal of Pharmacology|January 1, 1994
Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestatP D Taylor, A D Wickenden, D J Mirrlees, et al.British Journal of Pharmacology|May 1, 1991
Comparison of the effects of the K(+)-channel openers cromakalim and minoxidil sulphate on vascular smooth muscleA D Wickenden, S Grimwood, T L Grant, et al.Molecular Pharmacology|August 23, 2000
Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channelsA D Wickenden, W Yu, A Zou, et al.Pageof 3